Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 June 2020 | Story Rulanzen Martin | Photo Rulanzen Martin
Prof Kobus Marais, the founder of the JTSA, at the launch of his Indexicality Research Forum in 2019.

The newly launched Journal for Translation Studies in Africa (JTSA) by Prof Kobus Marais from the Department of Linguistics and Language Practice at the University of the Free State (UFS), is the result of various efforts over a period of more than a decade.

“The first Summer School for Translation Studies in Africa 2009 stands out as one of the first efforts to think about the concept of translation in Africa,” said Prof Marais. A subsequent series of summer schools also led to the formation of the Association for Translation Studies (ATSA) in Africa in 2016 in Nairobi, Kenya. 

The journal is an open-sourced, peer-reviewed publication, boasting scholarly papers, book reviews, opinion pieces and work by young scholars within translation studies. The first edition of the journal was made possible with financial support from Prof Corli Witthuhn, Vice-Rector: Research, Innovation and Internationalisation and the Directorate: Research Development at the UFS. 


First edition to focus on African translation phenomena 

The JTSA is an attempt to start scholarly debate with a focus on Africa as a developmental context in which to study translation phenomena and practices. The first edition will guest edited by Dr Carmen Delgado Luchner from the University of Geneva who is an accredited European Union interpreter. In the editorial of the first edition, Prof Marais and Dr Delgado Luchner set out the vision of the journal, namely: “to offer a high-level publication outlet to translation-studies scholars from Africa, African translation-studies scholars in the diaspora and scholars in general working on African topics in translation studies”.

“It would disseminate their work in order to advance the field of translation studies in Africa and to position Africa in relation to the rest of the world as far as translation studies are concerned.”

The editorial board of the JTSA consists of Prof Kobus Marais, the editor-in-chief, who will be assisted by three sub-editors, who each take responsibility for one of the sections. They are: Dr Francis Ajayi – Agenda (opinion pieces); Dr Felix Awung – reviews; and Dr Mwamba Chibamba – New Voices (young scholars). 

Apart from the editorial board there is an International Advisory Board consisting of various translation scholars. “This journal will be devoted to translation studies in Africa, with its wealth of languages, its innovative and creative language and translation practices and policies,” said Prof Reine Meylaerts, Vice-Rector: Research Policy at Katholieke Universitiet Leuven, who serves on the advisory board. She also praised the JTSA for its multilingualism and being an example of Open Science. 

Other scholars on the advisory board are: Prof Rita Kothari (Ashoka University in India); Prof John Milton (University of São Paulo, Brazil); Prof Jacobus Naude (UFS); Prof Maria Tymoczko (University of Massachusetts, Amherst); and Prof Rita Wilson (Monash University). 

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept